ADPT vs MKC · rev $142.4M vs P/E 8.4, rev $3.81B
Adaptive Biotechnologies Corp (ADPT) versus McCormick & Company Incorporated (MKC) — a side-by-side from cached financials, not a winner call.
Adaptive Biotechnologies Corp (ADPT) is a diagnostics & research company listed on NASDAQ.
McCormick & Company Incorporated (MKC) is a packaged foods company listed on US.
Latest reported ADPT revenue for 2026-06-30 was $142.4M. Net income was -$59.8M. ADPT currently screens at market cap $2.69B.
Latest reported MKC revenue for 2026-05-31 was $3.81B. Net income was $1.17B. MKC currently screens at market cap $13.56B and trailing P/E 8.4.
ADPT currently screens at market cap $2.69B. MKC currently screens at market cap $13.56B and trailing P/E 8.4.
Not investment advice. Open the ADPT and MKC stock pages for the full models.
Not investment advice.